| Celebrity Cannabis! | Distribution | Edibles & CBD |
| BeerDaily.com | Events | Government |
| Media Kit | Growers | Manufacturing |
| Testing Labs | Stoner Photo Wall | SativaDaily.com |
| Contact | Contests | |
| Celebrity Cannabis! | Distribution | Edibles & CBD |
| BeerDaily.com | Events | Government |
| Media Kit | Growers | Manufacturing |
| Testing Labs | Stoner Photo Wall | SativaDaily.com |
| Contact | Contests | |
Harvest and Trulieve Celebrate One Year Anniversary of Recreational Cannabis Sales in Arizona Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States, today announced plans to celebrate the one year anniversary of recreational cannabis sales in Arizona through a series of in-store activations, product specials and celebrations. All Trulieve-affiliated Harvest locations will have doorbuster deals on January 21 - 22, and the company will host a rooftop event at The Clarendon Hotel on Saturday, January 22.
Harvest recorded Arizona's first sale of recreational cannabis on January 22, 2021. This occurred shortly after voters approved Proposition 207, which legalized the possession and use of marijuana for adults. All 17 Arizona-based Harvest dispensaries will commemorate the occasion with daily activations including doorbuster deals, BOGO scratcher cards and branded swag giveaways. Customers who spend more than $275 at any Arizona Trulieve-affiliated store on January 20 - 21 will have exclusive access to the Company's Clarendon Hotel rooftop celebration.
Festivities on January 22 will also include in-store celebrations featuring DJs, food and local vendors at Trulieve-affiliated Harvest dispensaries in Scottsdale, located at 15190 N Hayden Road; Tempe, located at 710 W Elliot Road; Phoenix, located at 2630 W. Indian School Road; and Mesa, located at 1150 W. McLellan Road.
Pick Your City
Arizona
- Arkansas
- California
- Colorado
- Florida
- Illinois
- Louisiana
- Michigan
- Minnesota
- Montana
- Nevada
- New Mexico
- North Dakota
- Ohio
- Oklahoma!
- Oregon
- Rhode Island
- Utah
- Washington
Cannabis DispensaryContests
More states coming soon! Support (or become!) Our Sponsors and it will happen faster!
 Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) (the "Company" or "PLUS"), a cannabis and hemp branded products company in the U.S., announces that it has filed an application in the Supreme Court of British Columbia (the "Court") in the Company's Companies' Creditors Arrangement Act (Canada) (the "CCAA") proceedings, seeking an order (the "Sanction Order") that, among other things: (i) sanctions the Company's amended plan of compromise, arrangement and reorganization dated January 17, 2022 (the "Plan"); and (ii) extends the stay period in the CCAA proceedings until the date that PricewaterhouseCoopers Inc., in its capacity as court-appointed monitor of the Company (in such capacity, the "Monitor") is discharged by further Court order. The Company's Sanction Order application is scheduled to be heard by the Court on January 21, 2022. Once granted, the Sanction Order will allow the Company to complete the restructuring transactions contemplated under the Plan and the Acquisition Agreement dated December 17, 2021 between the Company and Glass House Brands Inc. (the "Purchaser") (NEO: GLAS.A.U) (NEO: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF), as amended by the Amendment to Acquisition Agreement dated January 17, 2022 (the "Acquisition Agreement"). Pursuant to the Sanction Order, upon implementation of the Plan, and after distributions are made to the Company's noteholders as set forth in the Plan, the Company will distribute common shares of the Purchaser to its securities-holders through Odyssey Trust Company. The details of such distributions, as well as of all distributions proposed to be made to the Company's stakeholders under the Sanction Order, are set forth in the Plan. A copy of the Plan, along with all materials filed by the Company with the Court in support of the Sanction Order application, can be found on the Monitor's website at https://www.pwc.com/ca/plusproducts. |
 The Ritz-Carlton, Dallas, Texas' first and Dallas' only five-star hotel, proudly announces the multimillion dollar renovation completion of the 12,000 square foot luxury spa. Dallas-based design firm ForrestPerkins thoughtfully transformed The Spa at The Ritz-Carlton, Dallas into a tranquil and enchanted garden oasis, boasting delicate and timeless design work throughout. This reimagination breathes fresh air and modern luxury into The Spa, adding another five-star amenity to match the property's five-star service. "Our vision was to transform The Spa, choreographing an exquisite guest experience with a sense of place and individuality through attention to design, detail and service," said Scott Studstill, The Spa Director of The Ritz-Carlton, Dallas. "The Spa redesign does exactly that, offering a daily dose of nature in a luxurious and soothing setting, and we look forward to welcoming spa-goers to experience our elegant new look along with brand-new treatment options for a fresh, luxury spa experience." The intricate new design pulls inspiration from the rich and lushly manicured urban parks and gardens woven throughout the heart of Dallas. Just beyond The Spa doors – which feature weathered bronze handles resembling natural tree branches – spa-goers are greeted by one of the most notable design elements, a stunning and full-scale, hand-forged metal trellis, sculpted by local artist, Larry Whiteley, known for his artistic pieces inspired by nature. As guests pass underneath the sculpture upon entering The Spa, they can take in the intricate, yet delicate detailing, including the meticulously formed vines, leaves, flowers and blooms. Tranquility flows through each room as the overall color palate is made up of crisp whites and bronze metals with lilac, lavender, and blue accents, paying homage to the elegant orchid blooms nearby. Soaring ceilings create a domed lighting effect, and elegant light fixtures comprised of branches and crystals adorn each corridor. Watery abstract pieces of art thoughtfully hang in each room to offer an everyday dose of nature. |
 Recently within the hemp community, it's been theorized 11 cannabinoids from the hemp plant could help your health. A number of these hemp flower cannabinoids grow naturally within the plant. |
 Dama Financial ("Dama"), the nation's largest provider of access to banking and payment solutions for the cannabis industry, has entered into an agreement to acquire GrowFlow Corp. ("GrowFlow"), whose business management and compliance tools have processed more than $3.3 billion for cannabis retailers, cultivators, processors, and distributors. Combining Dama's fintech and payment solutions and GrowFlow's industry-leading software platform will create the most sophisticated, comprehensive solution for cannabis companies, integrating product, operations, compliance, and financial data in a more usable and flexible solution than any current offering in the industry. The highly scalable platform will fulfill the business needs and regulatory obligations of any licensed cannabis business — dispensary or wholesale — everywhere cannabis is legal in the United States. |
 Tiger Group is selling over 55 million pieces of brand-new hemp CBD wellness products, packaging and related accessories in a major liquidation event. Worth a total of approximately $15 million at cost, the inventory is available for immediate purchase at SoldTiger.com. "As we begin 2022, we are extremely pleased to be offering one of the largest inventories of this type of product mix to hit the secondary market," noted Jonathan Holiday, Director of Business Development, Tiger Commercial & Industrial. "Below-market pricing will be made available for buyers acquiring large quantities of the packaging and accessories. The inventory is suitable for cannabis, cosmetics, pharmaceutical and other companies, to package your product as well as purchase for your retail operations." |
 Benzinga, a financial news and data company recently acquired at a $300 million valuation, announced that the 14th Benzinga Cannabis Capital Conference, the world's biggest and most successful cannabis investing and finance event, will take place on April 20 and April 21, 2022, at the Fontainebleau Miami Beach hotel, in Miami, Florida. Enjoy exclusive opportunities for curated networking and unparalleled access to private deal flow. Hear directly from the executives of top-performing cannabis companies and get priceless insights from the world's leading cannabis investors, all in one place. |
List Your CDB, Indica, Sativa, Edibles and Dispensary Here Free.
Just Email: Editor@IndicaDaily.com
1-310-541-0015
Please send us your NEWS!
Largest Global Maker of Raw CBGa and CBDa Products, 101 Hemp, Highlights Breakthrough Research by Oregon State University on the Use of Cannabinoids to Prevent COVID 19 Infection 101 Hemp (https://101hemp.org/) recently noted a promising new study from Oregon State University already listed by the National Institution of Health: "Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants." The study explicitly concludes that raw cannabinoids CBDa and CBGa have been shown to effectively block COVID-19 (alpha and beta) by interfering with the virus's ability to enter human cells – thus preventing infection. It also concludes that CBDa and CBGa hemp products are "orally bioavailable and with a long history of safe human use, these cannabinoids, isolated or in hemp extracts, have the potential to prevent as well as treat infection by SARS-CoV-2." |
Numinus Announces Key Milestones in MAPS Sponsored MDMA Assisted Therapy for PTSD Clinical Trial Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI), a leader in psychedelics-focused mental healthcare, is pleased to announce that it has completed key steps to prepare to enroll participants at its clinics participating in "A multi-site open-label extension study of MDMA-assisted psychotherapy for PTSD (MAPPUSX)", sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS). The Canadian study sites, which will continue to study the safety of MDMA-assisted therapy in treating severe PTSD, under the leadership of MAPS Public Benefit Corporation (MAPS PBC) as study sponsor, have recently received regulatory authorization from Health Canada, ethical approval from an Institutional Review Board (IRB) and a Section 56 exemption from the Controlled Drug and Substance Act (Canada), which will allow the use of MDMA throughout the duration of the clinical trial. "We are thrilled that our talented team of doctors and researchers at Numinus are helping pave the path forward to greater access to safe psychedelic-assisted psychotherapy with this study further evaluating the safety of MDMA-assisted therapy in treating severe PTSD," says Payton Nyquvest, Founder and CEO, Numinus. "This is an exciting next step in the MAPPUSX study, happening at our clinics in both British Columbia and Quebec, and we look forward to how this work supports expanded collaboration with MAPS in the future." |
ACS Laboratory Announces New THCOa Safety Bundle Raising the standard for cannabis and hemp testing, ACS Laboratory, the largest hemp and cannabis testing facility in the eastern U.S., has developed the THCOa Safety Bundle Test, a testing panel to test for THC-O Acetate (THCOa), acetic anhydride and other specific cannabinoids. With the THCOa Safety Bundle, ACS Laboratory, a DEA-licensed laboratory, now tests for a total of 22 cannabinoids, more than any other cannabis or hemp lab in the U.S. Following the excitement of Delta-8 THC and Delta-10 THC, THCOa has recently been gaining attention. An acetylated form of THC, THCOa does not naturally occur in hemp or cannabis plants. To create it, chemical reactants, as well as a catalyst, are needed (it can be produced from Delta-8 and Delta-9 THC). "When creating our THCOa Safety Bundle, we not only took the time to create a method for THCOa, but also a method for the potential harmful chemical, acetic anhydride, that is used as a reactor – to ensure safety and purity for the consumer and for ACS Laboratory to continue to be a good corporate citizen," said Roger Brown, president of ACS Laboratory. "Although there is excitement surrounding this cannabinoid, safety is our main priority and we strongly encourage suppliers to test beyond potency to ensure safety." |
Canonic Announces Positive Results in Pre Clinical Studies in its Precise Product Program for Medical Cannabis  Canonic Ltd., focused on the development of medical grade cannabis products and a wholly-owned subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today positive results in pre-clinical studies in inflammatory and pain model systems conducted in Israel by Hadassah Medical Center in Jerusalem and by Migal - Galilee Research Institute in Kiryat Shmona. The results support the identification of specific cannabis varieties with heightened anti-inflammatory and pain relief properties for Canonic's medical cannabis Precise product line and have led to a patent application filing. In its Precise product line, Canonic aims to develop medical grade cannabis inflorescence and oil products that provide relief for patients for specific medical indications with a high level of consistency and specificity in its clinical effects. Canonic's first product candidates within the Precise program target pain relief and inflammation reduction and are planned to be launched in Israel during 2023, followed by a European expansion. According to industry estimates, the medical cannabis market in Europe is estimated to pass €1 billion in 2023. According to a broad health economic study run by the BfArM[1] conducted in Germany, which represents over 50% of the European market, pain relief was the most frequently treated medical indication representing more than 70% of the medical indications treated with medical cannabis or cannabis-based medicines[2]. The Israeli medical cannabis market includes over 105,000 licensed patients and is estimated at $260 million per year, with over 60% of medical cannabis in Israel prescribed for pain and inflammation indications[3]. |
 Louisiana medical cannabis operator expands footprint, reinforces commitment to enhancing product availability and patient access in the state. ... |
 Products Will Roll Out in 1300 Stores Across the U.S. Providing Quality CBD for Consumers Everywhere ... |
 Includes full spectrum hemp CBD formulations for Sleep, Calm, Recovery, Immunity, Daily Wellness, and THC-Free ... |
 The improved loyalty integration provides a frictionless experience for dispensaries and customers ... |
|
Plus Products Files Application Seeking Sanction Order To Complete Transaction With Glass House Brands Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) (the "Company" or "PLUS"), a cannabis and hemp branded products company in the U.S., announces that it has filed an application in the Supreme Court of British Columbia (the "Court") in the Company's Companies' Creditors Arrangement Act (Canada) (the "CCAA") proceedings, seeking an order (the "Sanction Order") that, among other things: (i) sanctions the Company's amended plan of compromise, arrangement and reorganization dated January 17, 2022 (the "Plan"); and (ii) extends the stay period in the CCAA proceedings until the date that PricewaterhouseCoopers Inc., in its capacity as court-appointed monitor of the Company (in such capacity, the "Monitor") is discharged by further Court order. The Company's Sanction Order application is scheduled to be heard by the Court on January 21, 2022. Once granted, the Sanction Order will allow the Company to complete the restructuring transactions contemplated under the Plan and the Acquisition Agreement dated December 17, 2021 between the Company and Glass House Brands Inc. (the "Purchaser") (NEO: GLAS.A.U) (NEO: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF), as amended by the Amendment to Acquisition Agreement dated January 17, 2022 (the "Acquisition Agreement"). Pursuant to the Sanction Order, upon implementation of the Plan, and after distributions are made to the Company's noteholders as set forth in the Plan, the Company will distribute common shares of the Purchaser to its securities-holders through Odyssey Trust Company. The details of such distributions, as well as of all distributions proposed to be made to the Company's stakeholders under the Sanction Order, are set forth in the Plan. A copy of the Plan, along with all materials filed by the Company with the Court in support of the Sanction Order application, can be found on the Monitor's website at https://www.pwc.com/ca/plusproducts. |
|
THE RITZ CARLTON, DALLAS DEBUTS MULTIMILLION DOLLAR SPA RENOVATION The Ritz-Carlton, Dallas, Texas' first and Dallas' only five-star hotel, proudly announces the multimillion dollar renovation completion of the 12,000 square foot luxury spa. Dallas-based design firm ForrestPerkins thoughtfully transformed The Spa at The Ritz-Carlton, Dallas into a tranquil and enchanted garden oasis, boasting delicate and timeless design work throughout. This reimagination breathes fresh air and modern luxury into The Spa, adding another five-star amenity to match the property's five-star service. "Our vision was to transform The Spa, choreographing an exquisite guest experience with a sense of place and individuality through attention to design, detail and service," said Scott Studstill, The Spa Director of The Ritz-Carlton, Dallas. "The Spa redesign does exactly that, offering a daily dose of nature in a luxurious and soothing setting, and we look forward to welcoming spa-goers to experience our elegant new look along with brand-new treatment options for a fresh, luxury spa experience." The intricate new design pulls inspiration from the rich and lushly manicured urban parks and gardens woven throughout the heart of Dallas. Just beyond The Spa doors – which feature weathered bronze handles resembling natural tree branches – spa-goers are greeted by one of the most notable design elements, a stunning and full-scale, hand-forged metal trellis, sculpted by local artist, Larry Whiteley, known for his artistic pieces inspired by nature. As guests pass underneath the sculpture upon entering The Spa, they can take in the intricate, yet delicate detailing, including the meticulously formed vines, leaves, flowers and blooms. Tranquility flows through each room as the overall color palate is made up of crisp whites and bronze metals with lilac, lavender, and blue accents, paying homage to the elegant orchid blooms nearby. Soaring ceilings create a domed lighting effect, and elegant light fixtures comprised of branches and crystals adorn each corridor. Watery abstract pieces of art thoughtfully hang in each room to offer an everyday dose of nature. |
|
Boston Hemp Inc., What Can Hemp Flower Cannabinoids Do For You? Recently within the hemp community, it's been theorized 11 cannabinoids from the hemp plant could help your health. A number of these hemp flower cannabinoids grow naturally within the plant. |
|
Dama Financial to Acquire GrowFlow Dama Financial ("Dama"), the nation's largest provider of access to banking and payment solutions for the cannabis industry, has entered into an agreement to acquire GrowFlow Corp. ("GrowFlow"), whose business management and compliance tools have processed more than $3.3 billion for cannabis retailers, cultivators, processors, and distributors. Combining Dama's fintech and payment solutions and GrowFlow's industry-leading software platform will create the most sophisticated, comprehensive solution for cannabis companies, integrating product, operations, compliance, and financial data in a more usable and flexible solution than any current offering in the industry. The highly scalable platform will fulfill the business needs and regulatory obligations of any licensed cannabis business — dispensary or wholesale — everywhere cannabis is legal in the United States. |
|
Tiger Group Offers $15 Million in Hemp CBD Wellness Products and Child Resistant Packaging and Related Accessories in Major Liquidation Tiger Group is selling over 55 million pieces of brand-new hemp CBD wellness products, packaging and related accessories in a major liquidation event. Worth a total of approximately $15 million at cost, the inventory is available for immediate purchase at SoldTiger.com. "As we begin 2022, we are extremely pleased to be offering one of the largest inventories of this type of product mix to hit the secondary market," noted Jonathan Holiday, Director of Business Development, Tiger Commercial & Industrial. "Below-market pricing will be made available for buyers acquiring large quantities of the packaging and accessories. The inventory is suitable for cannabis, cosmetics, pharmaceutical and other companies, to package your product as well as purchase for your retail operations." |
|
Largest Gathering Of Sophisticated Cannabis Investors & Operators Returns To Miami April 20th, Hosted By Benzinga Benzinga, a financial news and data company recently acquired at a $300 million valuation, announced that the 14th Benzinga Cannabis Capital Conference, the world's biggest and most successful cannabis investing and finance event, will take place on April 20 and April 21, 2022, at the Fontainebleau Miami Beach hotel, in Miami, Florida. Enjoy exclusive opportunities for curated networking and unparalleled access to private deal flow. Hear directly from the executives of top-performing cannabis companies and get priceless insights from the world's leading cannabis investors, all in one place. |
 Green Roads also relaunched its DTC e-commerce experience to carry the Own the Day messaging and prominently feature the solutions and personas featured in the campaign. ... |
 ... |
 The Weldon Project was founded by Weldon Angelos, who served thirteen years of a fifty-five-year mandatory federal prison sentence for selling less than $1,000 of cannabis. ... |
 "Stop perpetuating a regressive War on Drugs 2.0! Save social equity operators and small legacy farmers with tax relief now!" ... |
Feds Loosen Grip on Cannabis Royal Emerald Pharmaceuticals (REP) is proud to announce that it has received four federal licenses to grow, research, develop, and manufacture alternative drugs derived from cannabis (marijuana) and other botanicals in December 2021. REP is the first-of-its-kind cannabis pharmaceutical company in the United States to receive these highly coveted licenses. The Drug Enforcement Administration (DEA) issued three licenses for bulk manufacturing, analytical lab and import in December. An earlier license was issued for distribution. Now, REP has all four federal (DEA) licenses needed to move forward with their next phase of development. This latest move by the DEA is a clear message that the federal government is loosening its grip on marijuana specifically grown for research purposes. It has been a long and hard battle for entrepreneurs in the cannabis industry to win approval from the DEA, but now it has finally happened. "We are excited and very happy to receive these DEA licenses for cannabis research," said Mark Crozier, Founder and CEO of Royal Emerald Pharmaceuticals. "This news is huge and comes with immense responsibilities - we have been chosen to provide researchers and universities with high quality cannabis so they can move forward with their research projects. These researchers have struggled for decades to be recognized by the medical and scientific communities. Now, they can," Crozier said. REP's main campus is a 100,000 square foot facility located on Palm Drive in Desert Hot Springs. REP expects to hire 250 employees to staff the grow and research facility in early 2022, and up to 1,000 employees after phase two is completed. |
Madwell, The Ad Council, and NHTSA Tackle the Topic of Drug Impaired Driving Independent creative agency Madwell teamed up with The Ad Council and the U.S. Department of Transportation's National Highway Traffic Safety Administration (NHTSA) to launch PSAs that aim to get marijuana users to think twice before getting behind the wheel and driving while high. The work is part of NHTSA and The Ad Council's Drug-Impaired Driving Prevention campaign, which launched in spring 2019 to address this pressing traffic safety issue, which is growing increasingly important as more states legalize the sale and usage of marijuana. Research indicates that young men do not believe consuming marijuana has an effect on their driving. Thus, the challenge for this campaign is to create doubt in this long-standing claim, while taking into account that the young male target trusts their experiences over experts, especially when it comes to something as polarizing as marijuana usage, and is highly resistant to being told what to do. "Our strategy focused on solving a timeless paradox," said Amber Hahn, Madwell's SVP, Head of Integrated Strategy. "We know young men are resistant to messages from enforcers and experts, particularly around topics like marijuana use. The best way to begin to change attitudes and behavior on this issue is to frame it up through the lens of their personal experience, as if it was coming from a peer." In a 15-second spot titled "I'm in an Ad," the hero, in a smoky house party, breaks character (and the 4th wall) to remind the audience not to drive if they're high. As the lights go up, the smoke-filled room is revealed to actually be a studio set. |
Compliance Topics Related to the COVID 19 Pandemic Top the Regulatory Issues Facing Businesses in 2022 Paychex, Inc., a leading provider of integrated human capital management software solutions for human resources, payroll, benefits, and insurance services, today shared the top 10 regulatory issues that employers should monitor in 2022. The list, compiled annually by the team of regulatory compliance experts at Paychex, identifies the items that should be top of mind as business owners and HR leaders continue to manage the impacts of the COVID-19 pandemic and plan for the year ahead. "Policies enacted in response to the COVID-19 will continue to dominate the regulatory landscape in 2022, which will also include issues such as paid leave, retirement, and others that affect a company's business and HR operations," said Frank Fiorille, vice president of risk, compliance, and data analytics at Paychex. "Our team of 200+ compliance experts are monitoring changes in federal, state, and local jurisdictions to understand new laws and regulations as quickly as possible, then we use that knowledge to inform and help guide our clients, so they have a better understanding of how these measures impact their business." |
University of Denvers Center for Professional Development Launches Cannabis Certificate Programs The University of Denver's Center for Professional Development is partnering with cannabis education company Green Flower to offer three non-credit cannabis certificate programs to help provide a skilled workforce in the fast-growing Colorado cannabis industry. The new certificate programs are The Business of Cannabis, Cannabis Healthcare and Medicine, and Cannabis Agriculture and Horticulture. All courses are delivered online in a self-paced format to meet the needs of busy adults. As the first state to legalize recreational cannabis, Colorado has been a leader in industry growth, reporting $1.77 billion in cannabis sales and 34,700 cannabis-related jobs in 2020. Nationwide, legal cannabis worker jobs are projected to grow by 250 percent by 2028, outpacing other fast-growing careers. This growth is creating increased demand for a workforce skilled in various aspects of the industry, and the University of Denver cannabis certificates aim to fill that need. |
| Celebrity Cannabis! | Distribution | Edibles & CBD |
| BeerDaily.com |
